Navigation Links
Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
Date:9/22/2008

WAYNE, Penn., Sept. 22 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that at this time Encorium and Prologue have mutually agreed to postpone negotiations regarding Encorium's planned acquisition of Prologue. Instead, the management teams of the two companies have decided to form a strategic partnership while leaving open the possibility of restarting negotiations relating to a merger of the two entities at a later date.

In conjunction with the postponement of negotiations with Prologue, Encorium's management and Board has initiated a strategic reorganization designed to cut costs and preserve capital. As an initial action to achieve profitability, Encorium is announcing an immediate reduction of its staff in the United States by approximately 18%. In addition to this and other immediate actions to improve profitability in its U.S. and European operations, Encorium will focus its management energies on intracompany sales growth as well. The Company also announced that it has engaged Mufson Howe Hunter & Company LLC to investigate possible strategic alternatives to maximize shareholder value.

"While we are disappointed we could not reach a final agreement on the acquisition at this time, in light of the strong strategic and cultural fit between Encorium and Prologue and their respective management teams, we believe that the formation of a strategic partnership will enable us to realize many of the potential benefits that a transaction could have created," stated Kai Lindevall, Executive Chairman of the Board of Enc
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
3. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
4. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
5. Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
6. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
7. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
8. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
9. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
10. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
11. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... COLORADO SPRINGS, Colo. , July 31, 2014 ... Company specializing in cannabis formulation-based drug development and ... has commenced production of multiple strains of cannabis ... scientific research to select the best strains for ... to bring the cannabis formulations to market for ...
(Date:7/31/2014)... Texas , July 31, 2014 Vermillion, Inc. ... and women,s health, will hold a conference call on Thursday, ... results for the second quarter ended June 30, 2014. Financial ... the call. Vermillion,s Chairman, President and CEO ... question and answer period. Date: Thursday, August 14, ...
(Date:7/31/2014)... , July 31, 2014  Today, ... a new extension to its PageCenterX ® ... software is designed to provide downtime reporting capabilities ... outages. LRS is releasing the product for general ... environment, EMR applications experience outages for a variety ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2LRS Announces Downtime Reporting Solution for Healthcare 2
... SEATTLE, WA, Nov. 13 Omeros Corporation (Nasdaq: ... and commercializing products focused on inflammation and disorders of ... hold a conference call on Thursday, November 19, 2009 ... provide a corporate update. Gregory A. Demopulos, M.D., Chairman ...
... EDDA Technology today announced the completion of ... an advanced clinical application designed to enhance efficiency ... planning. , IQQA®-Liver provides a comprehensive toolset ... liver lobes and segments, hepatic lesions, and vascular ...
Cached Medicine Technology:Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19 2EDDA Technology Completes CE Mark for IQQA(R)-Liver for Fast Quantitative Volumetry Assessment from Liver MDCT 2EDDA Technology Completes CE Mark for IQQA(R)-Liver for Fast Quantitative Volumetry Assessment from Liver MDCT 3
(Date:8/1/2014)... Stress management can be difficult in this day and ... diminish rest and leisure time, stress can mount up and ... a way to manage stress in order to be healthy ... good sense of work-life balance is the key to managing ... of SF Custom Chiropractic. “Stress, left unchecked, can not only ...
(Date:8/1/2014)... 2014 iFitDress.com, a professional company of ... collection of 2014 silver bridesmaid dresses recently. ... to the latest fashion trends. What’s more, they are ... percent off. , iFitDress.com is one of the ... not only silver bridesmaid gowns, but also many other ...
(Date:7/31/2014)... July 31, 2014 Serious buyer, Andrew ... Acid Test concert posters. Owsley Bear Stanley, the King ... the Grateful Dead. According to Hawley, “The Grateful Dead ... acid test parties in San Francisco and Los Angeles ... on three different colors of paper. They were a ...
(Date:7/31/2014)... birth control pills containing high-dose estrogen and a few ... whereas women using some other formulations did not, according ... journal of the American Association for Cancer Research. , ... [birth control pills] in the past year is associated ... or former oral contraceptive use, and that this risk ...
(Date:7/31/2014)... The 2013 PolyU TSI hit a record ... in 2012. The index measures inbound tourists’ satisfaction ... into an overall index. The 2013 index indicates ... Hong Kong over time. , The index shows ... in Hong Kong are attractions (79.27) and transportation ...
Breaking Medicine News(10 mins):Health News:SF Custom Chiropractic Celebrates National Relaxation Day and the Benefits of Massage Therapy for the Month of August 2Health News:iFitDress.com: Beautiful Silver Bridesmaid Dresses at Promotional Prices 2Health News:Recent use of some birth control pills may increase breast cancer risk 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3
... the Journal of Hospital Medicine , the risk ... upon general medicine inpatients and those with at least ... factors such as having cancer, chronic diseases such as ... medications, the studies identified other factors which increase the ...
... drugs that target specific molecular mechanisms of cancer have improved ... benefits may come with a cost to the patient,s sex ... the European Society for Medical Oncology (ESMO) in Milan, Italy, ... investigate the impact of cancer therapy on the sexual functioning ...
... Dr. David Nabarro, Assistant Secretary-General at the United Nations and ... Food Security Crisis, will deliver the keynote address at the ... Security on Tuesday, Oct. 19, 5 p.m., at Centre Mont-Royal, ... offer a global perspective on prospects for food and nutrition ...
... HealthDay Reporter , TUESDAY, Oct. 12 (HealthDay News) -- ... just as well as those who receive more, new research ... among U.S. hospitals. The studies are published in the ... Medical Association . In the first study, researchers in ...
... virusrelated virus (XMRV) has been the subject of many ... have created an unclear picture of XMRV,s role in ... November 15 issue of The Journal of Infectious ... possible link between XMRV and prostate cancer but not ...
... a synthetic molecule they designed can block activation of a ... some of those cancer cells to survive chemotherapy. ... cells appear to be protected from the toxic effects of ... protein from protecting the cells, the research suggests. As a ...
Cached Medicine News:Health News:Hospital readmission studies: Influencing factors identified 2Health News:Hospital readmission studies: Influencing factors identified 3Health News:Sexual issues a major concern for cancer patients taking new targeted drugs 2Health News:Coordinator of UN high-level task force to open McGill Food Security Conference 2Health News:Heart Surgery Patients Do Fine With Fewer Blood Transfusions: Study 2Health News:Heart Surgery Patients Do Fine With Fewer Blood Transfusions: Study 3Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3Health News:Blocking an oncogene in liver cancer could be potential therapy option 2Health News:Blocking an oncogene in liver cancer could be potential therapy option 3
Smartepil II is a laser particularly indicated for hair-removal where it has proved to be a valid instrument, even in the treatment of darker phototypes and telangiectasias of the face and legs....
... Tri-Active is the result of ... the combination of three different methods ... to your skin. This treatment is ... of cellulite through the combined action ...
... is a CO2 laser system with ... Its functions in continuous and super-pulsed ... extreme laser intervention delicacy. Excellent as ... it comes with a large LCD ...
... professional digital imaging system for ophthalmology and ... to acquire, analyze, and store your patient ... use the most are,available right on the ... easily. This high-resolution system supports images captured ...
Medicine Products: